DuPont Decomposition

Why does NURECA earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

0.4% = 0.8% × 0.52 × 1.08

Latest: FY2025

Profitability

Net Margin

0.8%

17.6% →0.8%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.52x

1.17x →0.52x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.08x

1.08x →1.08x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 21.7 pp over 4 years. Driven by net margin declining (17.6% → 0.8%), asset turnover declining (1.17x → 0.52x).

Historical Decomposition

Last 4 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr0Cr17.6%1.171.0822.1%
FY20230Cr-0Cr-7.4%0.541.06-4.2%
FY20240Cr-0Cr-1.9%0.451.06-0.9%
FY20250Cr0Cr0.8%0.521.080.4%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for NURECA

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

NURECA DuPont Analysis — ROE 0.4% | YieldIQ